These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32702453)

  • 1. Experimental study on the reduction of loratadine particle size through confined liquid impinging jets.
    Emami MS; Haghshenasfard M; Zarghami R; Sadeghi R; Esfahany MN
    Int J Pharm; 2020 Sep; 587():119668. PubMed ID: 32702453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.
    Alshweiat A; Katona G; Csóka I; Ambrus R
    Eur J Pharm Sci; 2018 Sep; 122():94-104. PubMed ID: 29908301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation on the use of confined liquid impinging jets for the synthesis of nanodrug particles.
    Chiou H; Chan HK; Prud'homme RK; Raper JA
    Drug Dev Ind Pharm; 2008 Jan; 34(1):59-64. PubMed ID: 18214756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosized-Loratadine Embedded Orodispersible Films for Enhanced Bioavailability: Scalable Preparations and Characterizations.
    Van Nguyen K; Nguyen HT; Nghiem LHT; Van Can M; Tran TH
    AAPS PharmSciTech; 2022 Feb; 23(3):78. PubMed ID: 35194702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the Production of Chitosan-Coated Polycaprolactone Nanoparticles in a Confined Impinging Jet Reactor.
    Zelenková T; Mora MJ; Barresi AA; Granero GE; Fissore D
    J Pharm Sci; 2018 Apr; 107(4):1157-1166. PubMed ID: 29221991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution behaviour of a nanoparticle in a microscale volume of solvent: thermodynamic and kinetic considerations.
    Vogelsberger W; Schmidt J
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():8-16. PubMed ID: 19558228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the relative performance of a confined impinging jets mixer and a multi-inlet vortex mixer for curcumin nanoparticle production.
    Chow SF; Sun CC; Chow AH
    Eur J Pharm Biopharm; 2014 Oct; 88(2):462-71. PubMed ID: 25016977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution enhancement of gliclazide using ultrasound waves and stabilizers in liquid anti-solvent precipitation.
    Al-Nimry SS; Qandil AM; Salem MS
    Pharmazie; 2014 Dec; 69(12):874-80. PubMed ID: 25951659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation.
    Yang D; Li R; Zhang F; Qin L; Peng F; Jiang S; He H; Lu X; Zhang P
    Drug Deliv Transl Res; 2020 Feb; 10(1):192-201. PubMed ID: 31482518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation concentration effect of propyleneglycol, glycerin, and polyethyleneglycol 400 to physical properties and dissolution rate of loratadine liquisolid tablet.
    Eryani MC; Hendradi E; Siswandono
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):583-587. PubMed ID: 34214337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Int J Pharm; 2009 Jun; 375(1-2):84-8. PubMed ID: 19481693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characteristics and
    Sarheed O; Shouqair D; Ramesh K; Amin M; Boateng J; Drechsler M
    Ther Deliv; 2020 Nov; 11(11):685-700. PubMed ID: 33225838
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications.
    Lince F; Marchisio DL; Barresi AA
    J Colloid Interface Sci; 2008 Jun; 322(2):505-15. PubMed ID: 18402975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of stable nanoemulsions by ultrasound-assisted two-step emulsification process for topical drug delivery: Effect of oil phase composition and surfactant concentration and loratadine as ripening inhibitor.
    Sarheed O; Shouqair D; Ramesh KVRNS; Khaleel T; Amin M; Boateng J; Drechsler M
    Int J Pharm; 2020 Feb; 576():118952. PubMed ID: 31843549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the use of tert-butanol/water cosolvent systems in production and freeze-drying of poly-ε-caprolactone nanoparticles.
    Zelenková T; Barresi AA; Fissore D
    J Pharm Sci; 2015 Jan; 104(1):178-90. PubMed ID: 25421731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size control in production and freeze-drying of poly-ε-caprolactone nanoparticles.
    Zelenková T; Fissore D; Marchisio DL; Barresi AA
    J Pharm Sci; 2014 Jun; 103(6):1839-50. PubMed ID: 24737658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.